EGFR mutation testing and personalised treatment in advanced NSCLC
Ever wondered what experts think about EGFR mutation rates and personalised treatment for advanced non-small cell lung cancer (NSCLC) in your country?
Read the latest insights from those working on the ground in lung cancer; healthcare professionals and patient group representatives from Wester Europe and North America.
This insights report helps contextualise similarities, diferences and barriers in daily practice across countries about EGFR mutation testing and personalised treatment.
DOWNLOAD PDF (1.82 MB)
Aumentare l’uso del test per la mutazione del gene EGFR nel carcinoma polmonare non a piccole cellule avanzato - notizie dal mondo